107 related articles for article (PubMed ID: 31985226)
1. An NMR-Based Chemometric Strategy to Identify
Casanova LM; Rodrigues LM; de Aguiar PF; Tinoco LW
J Nat Prod; 2020 Feb; 83(2):243-254. PubMed ID: 31985226
[TBL] [Abstract][Full Text] [Related]
2. Insights into nucleoside hydrolase from Leishmania donovani inhibition: A new bioaffinity chromatography-based screening assay and docking studies.
Anchau Wegermann C; Santana Bezerra E; Gomes de Macedo Sant'Anna I; Ortega De Oliveira PC; da Costa Silva R; Rocco Machado T; Wanderley Tinoco L; Vieira de Souza MCB; Pascutti P; Santos Boechat FDC; de Moraes MC
Bioorg Chem; 2024 May; 146():107302. PubMed ID: 38521010
[TBL] [Abstract][Full Text] [Related]
3. High-resolution inhibition profiling and ligand fishing for screening of nucleoside hydrolase ligands in Moringa oleifera Lamarck.
de Faria RA; Oliveira PCO; de Carvalho MDP; Peixoto BS; Severino VGP; Tinoco LW; Rodrigues SV; de Moraes MC
J Pharm Biomed Anal; 2022 Mar; 211():114614. PubMed ID: 35123329
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.
Rennó MN; França TC; Nico D; Palatnik-de-Sousa CB; Tinoco LW; Figueroa-Villar JD
Eur J Med Chem; 2012 Oct; 56():301-7. PubMed ID: 22947894
[TBL] [Abstract][Full Text] [Related]
5. New
Nirma C; Rangel GT; Alves MA; Casanova LM; Moreira MM; Rodrigues LM; Hamerski L; Tinoco LW
RSC Adv; 2019 Jun; 9(32):18663-18669. PubMed ID: 35515226
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and spectrophotometric analysis of nucleoside hydrolase from Leishmania chagasi (LcNH).
Sales EM; Sousa GS; Belouezzane C; Almeida FCL; Figueroa-Villar JD
Protein Expr Purif; 2019 Sep; 161():40-48. PubMed ID: 31034876
[TBL] [Abstract][Full Text] [Related]
7. A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.
Cui L; Rajasekariah GR; Martin SK
Gene; 2001 Dec; 280(1-2):153-62. PubMed ID: 11738828
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside hydrolase immobilized on magnetic particles as a tool for onflow screening and characterization of inhibitors.
de Oliveira PCO; Ceroullo MS; Dos Santos MB; Medeiros PRC; Marques BCB; Tinoco LW; de Souza MCBV; da Costa Santos Boechat F; de Moraes MC
J Pharm Biomed Anal; 2023 Oct; 235():115589. PubMed ID: 37531732
[TBL] [Abstract][Full Text] [Related]
9. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
Kashyap M; Jaiswal V; Farooq U
Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
[TBL] [Abstract][Full Text] [Related]
10. The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review.
Figueroa-Villar JD; Sales EM
Chem Biol Interact; 2017 Feb; 263():18-27. PubMed ID: 27939867
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors.
Berg M; Bal G; Goeminne A; Van der Veken P; Versées W; Steyaert J; Haemers A; Augustyns K
ChemMedChem; 2009 Feb; 4(2):249-60. PubMed ID: 19115304
[TBL] [Abstract][Full Text] [Related]
12. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis.
McAtee CP; Seid CA; Hammond M; Hudspeth E; Keegan BP; Liu Z; Wei J; Zhan B; Arjona-Sabido R; Cruz-Chan V; Dumonteil E; Hotez PJ; Bottazzi ME
Protein Expr Purif; 2017 Feb; 130():129-136. PubMed ID: 27773761
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani.
Gamboa-León R; Paraguai de Souza E; Borja-Cabrera GP; Santos FN; Myashiro LM; Pinheiro RO; Dumonteil E; Palatnik-de-Sousa CB
Vaccine; 2006 May; 24(22):4863-73. PubMed ID: 16635538
[TBL] [Abstract][Full Text] [Related]
15. NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.
Stockman BJ; Kaur A; Persaud JK; Mahmood M; Thuilot SF; Emilcar MB; Canestrari M; Gonzalez JA; Auletta S; Sapojnikov V; Caravan W; Muellers SN
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305530
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-å crystal structure.
Shi W; Schramm VL; Almo SC
J Biol Chem; 1999 Jul; 274(30):21114-20. PubMed ID: 10409664
[TBL] [Abstract][Full Text] [Related]
17. Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.
Alam R; Barbarovich AT; Caravan W; Ismail M; Barskaya A; Parkin DW; Stockman BJ
Chem Biol Drug Des; 2018 Oct; 92(4):1736-1742. PubMed ID: 29808562
[TBL] [Abstract][Full Text] [Related]
18. Proton NMR lipid profile of Leishmania donovani promastigotes.
Adosraku RK; Anderson MM; Anderson GJ; Choi G; Croft SL; Yardley V; Phillipson JD; Gibbons WA
Mol Biochem Parasitol; 1993 Dec; 62(2):251-62. PubMed ID: 8139618
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.
Santana DM; Borja-Cabrera GP; Paraguai de Souza E; Sturm NR; Palatnik de Sousa CB; Campbell DA
Mol Biochem Parasitol; 2002 Apr; 120(2):315-9. PubMed ID: 11897139
[No Abstract] [Full Text] [Related]
20. Inhibition of proinflammatory mediators by coumaroyl lupendioic acid, a new lupane-type triterpene from Careya arborea, on inflammation-induced animal model.
Begum R; Sheliya MA; Mir SR; Singh E; Sharma M
J Ethnopharmacol; 2017 Jul; 206():376-392. PubMed ID: 28502905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
